W. Hofstetter

发表

Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer

S. Swisher, T. Buchholz, Steven H. Lin, 2016, Cancer.

“Seedling” Mesenchymal Tumors (Gastrointestinal Stromal Tumors and Leiomyomas) are Common Incidental Tumors of the Esophagogastric Junction

A. Krasinskas, S. Swisher, Tsung-Teh Wu, 2007, The American journal of surgical pathology.

Putative Tumor-Suppressive Function of Krüppel-Like Factor 4 in Primary Lung Carcinoma

Li Wang, S. Swisher, W. Hofstetter, 2009, Clinical Cancer Research.

The Incremental Value of Subjective and Quantitative Assessment of 18F-FDG PET for the Prediction of Pathologic Complete Response to Preoperative Chemoradiotherapy in Esophageal Cancer

Laurence E Court, Marco van Vulpen, David V Fried, 2016, The Journal of Nuclear Medicine.

Pathologic T0N1 esophageal cancer after neoadjuvant therapy and surgery: an orphan status.

Joe Y. Chang, Min P. Kim, J. Ajani, 2010, The Annals of thoracic surgery.

Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Quan P. Ly, Michael Gibson, Rajesh N Keswani, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Evaluation of the American Joint Committee on Cancer 8th edition staging system for gastric cancer patients after preoperative therapy

J. Ajani, W. Hofstetter, P. Das, 2017, Gastric Cancer.

Double-Stranded RNA-Dependent Protein Kinase-Dependent Apoptosis Induction by a Novel Small Compound

S. Swisher, Wei Guo, W. Hofstetter, 2009, Journal of Pharmacology and Experimental Therapeutics.

Duplication of the Muscularis Mucosae in Barrett Esophagus: An Underrecognized Feature and Its Implication for Staging of Adenocarcinoma

A. Krasinskas, J. Ajani, S. Swisher, 2007, The American journal of surgical pathology.

Chemoradiotherapy Followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer

Sung-Bae Kim, D. Nieboer, J. Ajani, 2021, Annals of surgery.

A nomogram that predicts pathologic complete response to neoadjuvant chemoradiation also predicts survival outcomes after definitive chemoradiation for esophageal cancer.

J. Ajani, S. Swisher, Steven H. Lin, 2015, Journal of gastrointestinal oncology.

Factors Associated with Local–Regional Failure After Definitive Chemoradiation for Locally Advanced Esophageal Cancer

J. Ajani, J. Welsh, S. Swisher, 2013, Annals of Surgical Oncology.

Esophageal cancer dose escalation using a simultaneous integrated boost technique.

J. Ajani, D. Gomez, S. Swisher, 2012, International journal of radiation oncology, biology, physics.

Therapy-induced expression of NF-kappaB portends poor prognosis in patients with localized esophageal cancer undergoing preoperative chemoradiation.

J. Ajani, M. Hung, W. Hofstetter, 2009, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare Cohort.

J. Ajani, S. Swisher, T. Buchholz, 2009, International journal of radiation oncology, biology, physics.

Frequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma

J. Ajani, S. Swisher, A. Rashid, 2009, Cancer.

The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma

J. Ajani, J. Roth, S. Swisher, 2006, Cancer.

Obesity and outcomes in patients treated with chemoradiotherapy for esophageal carcinoma.

Joe Y. Chang, J. Ajani, S. Swisher, 2014, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline.

Laura H. Tang, K. Goodman, M. Shah, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumor and Stem Cell Biology Hippo Coactivator YAP 1 Upregulates SOX 9 and Endows Esophageal Cancer Cells with Stem-like Properties

J. Ajani, M. Hung, Randy L. Johnson, 2014 .

The value of 18F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinoma

D. Fried, L. Court, Steven H. Lin, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006–2014 using propensity score matching

J. Ajani, C. Roland, W. Hofstetter, 2018, Gastric Cancer.

Recurrence Risk Stratification After Preoperative Chemoradiation of Esophageal Adenocarcinoma

J. Ajani, Steven H. Lin, R. Komaki, 2017, Annals of surgery.

Utilization of surgery in trimodality-eligible patients with locally advanced esophageal adenocarcinoma in a nonprotocol setting.

J. Ajani, S. Swisher, R. Komaki, 2013, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Surgery Is an Essential Component of Multimodality Therapy for Patients with Locally Advanced Esophageal Adenocarcinoma

J. Ajani, J. Welsh, S. Swisher, 2013, Journal of Gastrointestinal Surgery.

Computed Tomography Findings Predicting Invasiveness of Thymoma

Edward S. Kim, S. Swisher, R. Komaki, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Gastric Cancer, Version 2.2013

M. Orringer, M. Washington, J. Ajani, 2013 .

A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries

Jing Wang, J. Ajani, Steven H. Lin, 2019, Disease Models & Mechanisms.

Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized Trial

J. Ajani, J. Roth, S. Swisher, 2018, Targeted Oncology.

KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression

Li Wang, S. Swisher, W. Hofstetter, 2010, Cancer biology & therapy.

Sonographic characteristics of locoregional lymph nodes that can predict the presence of metastatic carcinoma by endoscopic ultrasound-guided fine needle aspiration in patients with carcinomas of the esophagus/gastroesophageal junction

S. Krishnamurthy, W. Hofstetter, Jeffrey H. Lee, 2016, Esophagus.

Evolving role of endoscopic ultrasonography-guided fine-needle aspiration in tumor staging and treatment of patients with carcinomas of the upper gastrointestinal tract.

S. Krishnamurthy, W. Hofstetter, B. Weston, 2014, Journal of the American Society of Cytopathology.

Propensity-Based Matching between Esophagogastric Cancer Patients Who Had Surgery and Who Declined Surgery after Preoperative Chemoradiation

J. Ajani, S. Swisher, R. Komaki, 2013, Oncology.

stem-like properties to esophageal cancer cells Hippo coactivator YAP 1 upregulates SOX 9 and endows

J. Ajani, M. Hung, Randy L. Johnson, 2014 .

Cancer associated macrophage-like cells and prognosis of esophageal cancer after chemoradiation therapy

Steven H. Lin, R. Komaki, Z. Liao, 2020, Journal of Translational Medicine.

Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?

J. Ajani, W. Hofstetter, P. Das, 2016, Annals of Surgical Oncology.

JNK-deficiency enhanced oncolytic vaccinia virus replication and blocked activation of double-stranded RNA-dependent protein kinase

S. Swisher, W. Hofstetter, B. Fang, 2008, Cancer Gene Therapy.

Outcome of Trimodality-Eligible Esophagogastric Cancer Patients Who Declined Surgery after Preoperative Chemoradiation

J. Ajani, J. Welsh, S. Swisher, 2012, Oncology.

Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines.

M. Orringer, M. Washington, J. Ajani, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

Retrospective Study of Clinicopathologic Features and Prognosis of High-grade Neuroendocrine Carcinoma of the Esophagus

J. Ajani, S. Swisher, R. Komaki, 2008, The American journal of surgical pathology.

Targeting CDK9 and MCL-1 by a new CDK9/p-TEFb inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma

J. Ajani, Steven H. Lin, S. Kopetz, 2019, Therapeutic advances in medical oncology.

Gastric Cancer, Version 2.2022

Quan P. Ly, J. Ajani, J. Lacy, 2022 .

Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy.

R. Mohan, J. Ajani, Steven H. Lin, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

18FDG-PET/CT is useful in the follow-up of surgically treated patients with oesophageal adenocarcinoma.

Carol C Wu, W. Hofstetter, A. Correa, 2017, The British journal of radiology.

The Hippo coactivator YAP 1 mediates EGFR overexpression and confers chemo-resistance in esophageal cancer

J. Ajani, Tsung-Teh Wu, M. Hung, 2015 .

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

Quan P. Ly, J. Ajani, J. Lacy, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Influence of Preoperative Radiation Field on Postoperative Leak Rates in Esophageal Cancer Patients after Trimodality Therapy

S. Swisher, Steven H. Lin, R. Komaki, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Incidence of Brain Metastases after Trimodality Therapy in Patients with Esophageal or Gastroesophageal Cancer: Implications for Screening and Surveillance

J. Ajani, S. Swisher, R. Komaki, 2013, Oncology.

A Multicenter Study of Survival After Neoadjuvant Radiotherapy/Chemotherapy and Esophagectomy for ypT0N0M0R0 Esophageal Cancer

S. Swisher, J. Peters, A. Hölscher, 2010, Annals of surgery.

Gastric cancer.

M. Orringer, M. Washington, J. Ajani, 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: a systematic review and meta-analysis.

J. Ajani, S. Swisher, W. Hofstetter, 2012, Gastrointestinal endoscopy.

Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer.

J. Ajani, S. Swisher, R. Komaki, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246.

J. Ajani, S. Swisher, Tsung-Teh Wu, 2007, International journal of radiation oncology, biology, physics.

18F-FDG PET Response After Induction Chemotherapy Can Predict Who Will Benefit from Subsequent Esophagectomy After Chemoradiotherapy for Esophageal Adenocarcinoma

Steven H. Lin, R. Komaki, Z. Liao, 2017, The Journal of Nuclear Medicine.

Critical appraisal of locoregional failure and systemic disease progression after preoperative chemoradiation of esophageal adenocarcinoma. Reply to R. Gertler et al.

J. Ajani, W. Hofstetter, H. Skinner, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Author reply

J. Ajani, S. Swisher, W. Hofstetter, 2007 .

Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.

Quan P. Ly, M. Orringer, M. Washington, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Clinical Staging of Patients with Early Esophageal Adenocarcinoma: Does FDG-PET/CT Have a Role?

J. Ajani, J. Welsh, S. Swisher, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study

M. Cuesta, R. van Hillegersberg, K. Moorthy, 2019, BMC Cancer.

Distribution and Timing of Distant Metastasis after Local Therapy in a Large Cohort of Patients with Esophageal and Esophagogastric Junction Cancer

J. Ajani, W. Hofstetter, Jeffrey H. Lee, 2014, Oncology.

Celebrate or calibrate? We say calibrate.

J. Ajani, J. Welsh, S. Swisher, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Early clinical esophageal adenocarcinoma (cT1): Utility of CT in regional nodal metastasis detection and can the clinical accuracy be improved?

J. Ajani, J. Erasmus, B. Sabloff, 2017, European journal of radiology.

Hippo coactivator YAP1 upregulates SOX9 and endows stem-like properties to esophageal cancer cells

J. Ajani, M. Hung, Randy L. Johnson, 2014 .

Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study

M. Cuesta, R. van Hillegersberg, K. Moorthy, 2019, BMC Cancer.

Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas

J. Ajani, S. Swisher, Tsung-Teh Wu, 2007, Cancer.

Gastric Cancer, Version 3.2016; Clinical Practice Guidelines in Oncology

Quan P. Ly, M. Orringer, M. Washington, 2016 .

Anti-phosphorylated histone H3 expression in Barrett's esophagus, low-grade dysplasia, high-grade dysplasia, and adenocarcinoma

J. Ajani, S. Swisher, A. Rashid, 2009, Modern Pathology.

Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma

J. Ajani, Steven H. Lin, S. Kopetz, 2017, Oncotarget.

Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma

J. Ajani, Randy L. Johnson, W. Hofstetter, 2021, Gut.

RNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung cancer

J. Roth, I. Wistuba, S. Swisher, 2015, Oncotarget.

Genome-Wide Catalogue of Chromosomal Aberrations in Barrett's Esophagus and Esophageal Adenocarcinoma: A High-Density Single Nucleotide Polymorphism Array Analysis

Kenneth K Wang, J. Ajani, J. Gu, 2010, Cancer Prevention Research.

The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer

J. Ajani, Tsung-Teh Wu, M. Hung, 2015, Clinical Cancer Research.

IGFBP2/FAK Pathway Is Causally Associated with Dasatinib Resistance in Non–Small Cell Lung Cancer Cells

J. Minna, J. Roth, S. Swisher, 2013, Molecular Cancer Therapeutics.

Insulin-Like Growth Factor Binding Protein-2 Level Is Increased in Blood of Lung Cancer Patients and Associated with Poor Survival

Xifeng Wu, J. Roth, S. Swisher, 2013, PloS one.

IGFBP 2 / FAK pathway is causally associated with dasatinib resistance in non-small Cell Lung Cancer Cells

J. Minna, J. Roth, S. Swisher, 2013 .

Clinical Biology of Esophageal Adenocarcinoma after Surgery Is Influenced by Nuclear Factor-κB Expression

J. Ajani, S. Swisher, Tsung-Teh Wu, 2007, Cancer Epidemiology Biomarkers & Prevention.

Selective antitumor activity of ibrutinib in EGFR-mutant non-small cell lung cancer cells.

Michael L. Wang, J. Minna, J. Roth, 2014, Journal of the National Cancer Institute.

Expression of Annexin A1 in Esophageal and Esophagogastric Junction Adenocarcinomas: Association with Poor Outcome

J. Ajani, S. Swisher, Tsung-Teh Wu, 2006, Clinical Cancer Research.

Aberrant Expression of Proteins Involved in Signal Transduction and DNA Repair Pathways in Lung Cancer and Their Association with Clinical Parameters

Jing Wang, Li Wang, J. Roth, 2012, PloS one.

18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer

Jing Wang, I. Wistuba, J. Lee, 2020, Cancer Immunology, Immunotherapy.

TGF-b/b2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome

Nina M. Muñoz, Nipun A. Mistry, R. Weksberg, 2019 .

TGF-b / b 2-spectrin / CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome

Nina M. Muñoz, Nipun A. Mistry, R. Weksberg, 2019 .

TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome.

Nina M. Muñoz, Nipun A. Mistry, R. Weksberg, 2016, The Journal of clinical investigation.

Esophageal and esophagogastric junction cancers.

Quan P. Ly, Christopher Willett, Rajesh N Keswani, 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

Loss of TGF-β adaptor β2SP activates notch signaling and SOX9 expression in esophageal adenocarcinoma.

J. Ajani, W. Hofstetter, L. Mishra, 2013, Cancer research.

Molecular and Cellular Pathobiology Loss of TGF-b Adaptor b 2 SP Activates Notch Signaling and SOX 9 Expression in Esophageal Adenocarcinoma

J. Ajani, W. Hofstetter, L. Mishra, 2013 .

Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patients

J. Ajani, J. Erasmus, W. Hofstetter, 2017, Medical Oncology.

Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Quan P. Ly, Rajesh N Keswani, Kory Jasperson, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer.

Joe Y. Chang, K. Hess, J. Ajani, 2019, JAMA oncology.

Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial

Joe Y. Chang, J. Ajani, S. Swisher, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Failure patterns in patients with esophageal cancer treated with definitive chemoradiation

J. Ajani, R. Komaki, Z. Liao, 2012, Cancer.

A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246.

J. Ajani, S. Swisher, Tsung-Teh Wu, 2007, International journal of radiation oncology, biology, physics.

Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.

Daniel Gomez, Lei Dong, Zhongxing Liao, 2011, International journal of radiation oncology, biology, physics.

Preoperative Chemo-Radiation-Induced Ulceration in Patients with Esophageal Cancer: A Confounding Factor in Tumor Response Assessment in Integrated Computed Tomographic-Positron Emission Tomographic Imaging

R. Munden, J. Ajani, S. Swisher, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Significance of the Depth of Tumor Invasion and Lymph Node Metastasis in Superficially Invasive (T1) Esophageal Adenocarcinoma

J. Ajani, S. Swisher, Tsung-Teh Wu, 2005, The American journal of surgical pathology.

Esophageal Cancer

W. Hofstetter, 2020, Encyclopedia of Gastroenterology.

Taxane-based or platinum-based combination chemotherapy given concurrently with radiation followed by surgery resulting in high cure rates in esophageal cancer patients

J. Ajani, W. Hofstetter, Jeffrey H. Lee, 2020, Medicine.

Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial

J. Ajani, J. Roth, S. Swisher, 2017, British Journal of Cancer.

Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients

J. Ajani, S. Swisher, V. Baladandayuthapani, 2017, British Journal of Cancer.

101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative Therapy

J. Ajani, W. Hofstetter, Jeffrey H. Lee, 2017, Oncology.

A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer.

P. Thall, J. Ajani, J. Roth, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography

J. Ajani, S. Swisher, Z. Liao, 2010, Cancer.

The Standardized Uptake Value of 18-Fluorodeoxyglucose Positron Emission Tomography after Chemoradiation and Clinical Outcome in Patients with Localized Gastroesophageal Carcinoma

J. Ajani, S. Swisher, Z. Liao, 2010, Oncology.

The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma

J. Ajani, S. Swisher, Z. Liao, 2009, Cancer.

Influence of the baseline 18F‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiation

J. Ajani, S. Swisher, R. Komaki, 2009, Cancer.

Final Results of NRG Oncology RTOG 0246: An Organ‐Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation

J. Ajani, S. Swisher, Tsung-Teh Wu, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

ALDH‐1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients

J. Ajani, V. Baladandayuthapani, R. Komaki, 2014, Molecular oncology.

Metformin use and improved response to therapy in esophageal adenocarcinoma

T. Guerrero, J. Ajani, J. Welsh, 2013, Acta oncologica.

The Role of PKR/eIF2α Signaling Pathway in Prognosis of Non-Small Cell Lung Cancer

Ignacio I. Wistuba, Liping Yu, Yihong Zhou, 2011, PloS one.

Targeting CDK9 and MCL-1 by a new CDK9/p-TEFb inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma

J. Ajani, Steven H. Lin, S. Kopetz, 2019, Therapeutic advances in medical oncology.

Esophageal and Esophagogastric Junction Cancers Clinical Practice Guidelines in Oncology

M. Orringer, M. Washington, J. Ajani, 2011 .

Duplicated Muscularis Mucosae Invasion has Similar Risk of Lymph Node Metastasis and Recurrence-free Survival as Intramucosal Esophageal Adenocarcinoma

J. Ajani, S. Swisher, A. Rashid, 2011, The American journal of surgical pathology.

Effects of Intraoperative Opioid Use on Recurrence-Free and Overall Survival in Patients With Esophageal Adenocarcinoma and Squamous Cell Carcinoma

W. Hofstetter, J. Cata, G. Mena, 2018, Anesthesia and analgesia.

Salvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma.

Joe Y. Chang, J. Ajani, J. Roth, 2012, The Annals of thoracic surgery.

Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer.

Joe Y. Chang, R. Mohan, J. Ajani, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis.

Joe Y. Chang, J. Ajani, D. Gomez, 2017, International journal of radiation oncology, biology, physics.

Predictors of postoperative complications after trimodality therapy for esophageal cancer.

J. Ajani, S. Swisher, Steven H. Lin, 2013, International journal of radiation oncology, biology, physics.

Nodal Downstaging in Gastric Cancer Patients: Promising Survival if ypN0 is Achieved

J. Ajani, W. Hofstetter, B. Minsky, 2018, Annals of Surgical Oncology.

Co-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma

J. Ajani, W. Hofstetter, Jeffrey H. Lee, 2017, Annals of Surgical Oncology.

Factors Predictive of Improved Outcomes With Multimodality Local Therapy After Palliative Chemotherapy for Stage IV Esophageal Cancer

Steven H. Lin, R. Komaki, Z. Liao, 2016, American journal of clinical oncology.

Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma

Steven H. Lin, R. Komaki, Z. Liao, 2015, BMC Cancer.

Tumorigenesis and Neoplastic Progression MicroRNA-196 a Is a Potential Marker of Progression during Barrett ’ s Metaplasia-Dysplasia-Invasive Adenocarcinoma Sequence in Esophagus

S. Swisher, A. Rashid, W. Hofstetter, 2010 .

Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors

J. Ajani, B. Liu, Randy L. Johnson, 2017, British Journal of Cancer.

Tumor-associated macrophage infiltration is highly associated with PD-L1 expression in gastric adenocarcinoma

J. Ajani, Randy L. Johnson, W. Hofstetter, 2017, Gastric Cancer.

Patterns of Care and Treatment Outcomes of Elderly Patients with Stage I Esophageal Cancer: Analysis of the National Cancer Data Base

Steven H. Lin, W. Hofstetter, V. Verma, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Excellent Interobserver Agreement on Grading the Extent of Residual Carcinoma After Preoperative Chemoradiation in Esophageal and Esophagogastric Junction Carcinoma: A Reliable Predictor for Patient Outcome

A. Krasinskas, J. Ajani, L. Chirieac, 2007, The American journal of surgical pathology.

Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases

J. Ajani, S. Swisher, W. Hofstetter, 2020, Gastric Cancer.

High Expression of Folate Receptor Alpha in Lung Cancer Correlates with Adenocarcinoma Histology and Mutation

Milind B. Suraokar, J. Lee, W. Franklin, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Combined modality therapy of cT2N0M0 esophageal cancer

J. Ajani, S. Swisher, R. Komaki, 2011, Cancer.

Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma

R. van Hillegersberg, Steven H. Lin, L. Ho, 2018, Annals of Surgical Oncology.

Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using 18F-FDG PET/CT

R. van Hillegersberg, Steven H. Lin, L. Ho, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer.

P. Thall, J. Ajani, S. Swisher, 2012, International journal of radiation oncology, biology, physics.

Expression of Annexin A1in Esophageal and Esophagogastric Junction Adenocarcinomas: Associationwith Poor Outcome

J. Ajani, S. Swisher, Tsung-Teh Wu, 2006 .

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

N. Ajami, Jing Wang, I. Wistuba, 2023, Nature Medicine.

Validation of a Nomogram Predicting Survival After Trimodality Therapy for Esophageal Cancer.

R. van Hillegersberg, Steven H. Lin, C. Hallemeier, 2018, The Annals of thoracic surgery.

Validated biomarker signatures that predict pathologic response to preoperative chemoradiation therapy (CTRT) with high specificity and desirable sensitivity levels in patients with esophageal cancer (EC).

D. Berry, J. Ajani, J. Welsh, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multi-institutional Analysis of Recurrence and Survival After Neoadjuvant Chemoradiotherapy of Esophageal Cancer: Impact of Histology on Recurrence Patterns and Outcomes

Steven H. Lin, Mengzhong Liu, C. Hallemeier, 2019, Annals of surgery.

Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort.

J. Ajani, S. Swisher, W. Hofstetter, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy.

Steven H. Lin, R. Komaki, Z. Liao, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.

Quan P. Ly, J. Ajani, J. Lacy, 2023, Journal of the National Comprehensive Cancer Network : JNCCN.

Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy: A Nomogram Associated with Long-Term Survivors

J. Ajani, W. Hofstetter, R. Slack, 2016, Oncology.

HER2 Confers Resistance to Foretinib Inhibition of MET-Amplified Esophageal Adenocarcinoma Cells.

T. Pandita, S. Swisher, W. Hofstetter, 2017, The Annals of thoracic surgery.

Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006‐2014

Xianglin L. Du, J. Ajani, C. Roland, 2018, Cancer.

High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation

J. Roth, S. Swisher, W. Hofstetter, 2022, Annals of Surgery.

Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience.

J. Ajani, J. Roth, S. Swisher, 2019, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Impact of genomic aberrations and additional therapies on survival outcomes of patients with operable non-small cell lung cancer (NSCLC) from the NEOSTAR study.

J. Lee, S. Swisher, A. Tsao, 2021 .

A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Steven H. Lin, R. Komaki, Z. Liao, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer.

J. Ajani, J. Welsh, S. Swisher, 2012, European journal of cancer.

Update: Modern Approaches to the Treatment of Localized Esophageal Cancer

J. Ajani, D. Gomez, R. Komaki, 2011, Current oncology reports.

Targeting cyclin-dependent kinase 9 by a novel inhibitor enhances radiosensitization and identifies Axl as a novel downstream target in esophageal adenocarcinoma

J. Ajani, Steven H. Lin, M. Tetzlaff, 2019, Oncotarget.

Actionable Locoregional Relapses after Therapy of Localized Esophageal Cancer: Insights from a Large Cohort

J. Ajani, S. Swisher, R. Komaki, 2018, Oncology.

Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer.

J. Ajani, J. Welsh, S. Swisher, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis.

J. Ajani, J. Welsh, S. Swisher, 2012, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Frequency and Implications of Paratracheal Lymph Node Metastases in Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma.

J. Ajani, S. Swisher, W. Hofstetter, 2019, Annals of surgery.

Proton beam therapy and concurrent chemotherapy for esophageal cancer.

R. Mohan, J. Ajani, S. Swisher, 2012, International journal of radiation oncology, biology, physics.

A Nomogram to Predict Distant Metastases After Multimodality Therapy for Patients With Localized Esophageal Cancer.

J. Ajani, S. Swisher, R. Komaki, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Nomograms for Prognostication of Outcome in Patients with Esophageal and Gastroesophageal Carcinoma Undergoing Definitive Chemoradiotherapy

J. Ajani, J. Welsh, S. Swisher, 2012, Oncology.

Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy

J. Ajani, J. Welsh, S. Swisher, 2011, Cancer.

Utility of endoscopic ultrasound-guided fine-needle aspiration of regional lymph nodes that are proximal to and far from the primary distal esophageal carcinoma

N. Sneige, J. Ajani, S. Swisher, 2017, Oncotarget.

Celiac node failure patterns after definitive chemoradiation for esophageal cancer in the modern era.

J. Ajani, R. Komaki, Z. Liao, 2012, International journal of radiation oncology, biology, physics.

Outcomes with Esophageal Cancer Radiation Therapy

Joe Y. Chang, J. Ajani, S. Swisher, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Detection of interval distant metastases

R. Munden, J. Ajani, O. Mawlawi, 2007, Cancer.

Association of age and survival in patients with gastroesophageal cancer undergoing surgery with or without preoperative therapy

J. Ajani, J. Roth, S. Swisher, 2009, Cancer.

Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus

J. Ajani, S. Swisher, Z. Liao, 2008, Cancer.

Value of endoscopic ultrasound staging in conjunction with the evaluation of lymphovascular invasion in identifying low‐risk esophageal carcinoma

J. Ajani, S. Swisher, Tsung-Teh Wu, 2008, Cancer.

Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma patients who achieve a clinical complete response after chemoradiation.

J. Ajani, S. Swisher, R. Komaki, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Transesophageal EUS and EUS-FNA for lung cancer: where do we go from here?

W. Hofstetter, M. Bhutani, 2007, Journal of clinical gastroenterology.

Surgeon Assessment of Gastric Cancer Lymph Node Specimens with a Video of Technique

J. Ajani, J. Skibber, W. Hofstetter, 2018, Journal of Gastrointestinal Surgery.

The ypT category does not impact overall survival in node negative gastric cancer

J. Ajani, W. Hofstetter, B. Minsky, 2018, Journal of surgical oncology.

The newly proposed clinical and post-neoadjuvant treatment staging classifications for gastric adenocarcinoma for the American Joint Committee on Cancer (AJCC) staging

J. Ajani, W. Hofstetter, T. Sano, 2017, Gastric Cancer.

Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction

J. Ajani, S. Swisher, R. Komaki, 2010, Cancer.

Long-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: A large single-institutional cohort study

S. Swisher, Steven H. Lin, R. Komaki, 2017, Advances in radiation oncology.

Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications

J. Ajani, S. Swisher, R. Komaki, 2015, Oncology.

18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients.

J. Ajani, W. Hofstetter, H. Macapinlac, 2015, European journal of cancer.

Post-chemoradiation surgical pathology stage can customize the surveillance strategy in patients with esophageal adenocarcinoma.

J. Ajani, S. Swisher, R. Komaki, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Adenocarcinoma of the lower esophagus with Barrett's esophagus or without Barrett's esophagus: differences in patients' survival after preoperative chemoradiation.

J. Ajani, S. Swisher, R. Komaki, 2009, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma.

J. Ajani, J. Roth, S. Swisher, 2006, The Journal of thoracic and cardiovascular surgery.

Biologic risk model for recurrence in resected early-stage non-small cell lung cancer (ES NSCLC).

S. Lippman, R. Lotan, I. Wistuba, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Barrett’s Esophagus after Bimodality Therapy in Patients with Esophageal Adenocarcinoma

J. Ajani, W. Hofstetter, M. Davila, 2018, Oncology.

Predictors of postoperative complications after trimodality therapy for esophageal cancer.

J. Ajani, S. Swisher, Steven H. Lin, 2013, International journal of radiation oncology, biology, physics.

Results of a Phase II Randomized Trial of Proton Beam Therapy vs Intensity Modulated Radiation Therapy in Esophageal Cancer

P. Thall, R. Mohan, J. Ajani, 2019, International Journal of Radiation Oncology*Biology*Physics.

Total Lesion Glycolysis Assessment Identifies a Patient Fraction With a High Cure Rate Among Esophageal Adenocarcinoma Patients Treated With Definitive Chemoradiation.

J. Ajani, W. Hofstetter, Jeffrey H. Lee, 2019, Annals of surgery.

Prospective Phase 1/2 Clinical Trial: Evaluating Dose-Escalation for Esophageal Cancer

J. Ajani, D. Gomez, S. Swisher, 2015 .

Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population.

J. Roth, S. Swisher, C. Moran, 2009, The Journal of thoracic and cardiovascular surgery.

Association of clinical complete response (cCR) after preoperative chemoradiation and pathological complete response (pathCR) in patients with gastroesophageal cancer (GEC) and indispensability of trimodality therapy (TMT).

J. Ajani, J. Welsh, S. Swisher, 2012 .

Final results of RTOG 0246: A phase II study of selective surgical resection for locoregionally advanced esophageal cancer treated with a paclitaxel-based chemoradiation regimen.

J. Ajani, S. Swisher, Tsung-Teh Wu, 2013 .

Radiographic response to neoadjuvant therapy in pleural mesothelioma should serve as a guide for patient selection for cytoreductive operations.

J. Roth, K. Tomczak, A. Tsao, 2023, Frontiers in Oncology.

Concordance of studies for nodal staging is prognostic for worse survival in esophageal cancer.

J. Ajani, S. Swisher, W. Hofstetter, 2014, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Multifocal High-Grade Dysplasia (MFHGD) in Barrett's Esophagus Is Associated with Adenocarcinoma in Patients Undergoing Endoscopic Mucosal Resection (EMR) for Barrett's Esophagus

N. Fukami, W. Hofstetter, D. Maru, 2008 .

Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection.

Jeffrey E. Lee, Huamin Wang, R. Wolff, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data.

H. Ishwaran, R. Burger, V. Rusch, 2016, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Optimum Lymphadenectomy for Esophageal Cancer Methods Worldwide Esophageal Cancer Collaboration Multivariable Risk-adjusted Survival

H. Ishwaran, V. Rusch, C. Reed, 2022 .

The Role of PKR / eIF 2 a Signaling Pathway in Prognosis of Non-Small Cell Lung Cancer

Behrens, Ignacio I. Wistuba, Liping Yu, 2011 .

The Role of PKR/eIF2 alpha Signaling Pathway in Prognosis of Non-Small Cell Lung Cancer

Behrens, J. Roth, I. Wistuba, 2011 .

Worldwide Esophageal Cancer Collaboration: pathologic staging data.

H. Ishwaran, R. Burger, V. Rusch, 2016, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Worldwide Esophageal Cancer Collaboration: clinical staging data.

H. Ishwaran, R. Burger, V. Rusch, 2016, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY Esophageal and Esophagogastric Junction Cancers, Version 2.2019

J. Ajani, C. Willett, D. Bentrem, 2019 .

Localized Gastroesophageal Adenocarcinoma in the Elderly: Is Age a Factor Associated with Suboptimal Treatment?

J. Ajani, W. Hofstetter, Jeffrey H. Lee, 2022, Oncology.

The newly proposed clinical and post-neoadjuvant treatment staging classifications for gastric adenocarcinoma for the American Joint Committee on Cancer (AJCC) staging

J. Ajani, W. Hofstetter, T. Sano, 2017, Gastric Cancer.

Distribution and Timing of Distant Metastasis after Local Therapy in a Large Cohort of Patients with Esophageal and Esophagogastric Junction Cancer

J. Ajani, W. Hofstetter, Jeffrey H. Lee, 2014, Oncology.

Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized Trial

J. Ajani, J. Roth, S. Swisher, 2018, Targeted Oncology.

Esophageal and esophagogastric junction cancers, version 1.2015.

M. Orringer, M. Washington, J. Ajani, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome.

Nina M. Muñoz, Nipun A. Mistry, R. Weksberg, 2016, The Journal of clinical investigation.

High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation

J. Roth, S. Swisher, W. Hofstetter, 2022, Annals of surgery.

Clinical Staging of Patients with Early Esophageal Adenocarcinoma: Does FDG-PET/CT Have a Role?

J. Ajani, J. Welsh, S. Swisher, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.